All In Biotech

Drug Trial Radar · NCT07913009

Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Hepatic Impairment

An Open-Label Phase I Clinical Study to Compare the Pharmacokinetics and Safety Profile of Single Oral Administration of HSK31858 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Mar 16, 2026

Primary completion

Dec 2026

Study completion Jan 2027

Sponsor

Sponsor type
Industry
First posted
Nov 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is being conducted to compare the pharmacokinetics, safety of HSK31858 in subjects with mild, moderate, severe hepatic impairment and normal hepatic function.

Conditions

  • Non-cystic Fibrosis Bronchiectasis (NCFBE)

Interventions

  • HSK31858 tabletsDrug

    oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: Post-dose at day 1 to day 14.
  2. AUC0-tTime frame: Post-dose at day 1 to day 14.
  3. AUC0-∞Time frame: Post-dose at day 1 to day 14.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Henan Infectious Disease Hospital (Zhengzhou No.6 People's Hospital)

    Zhenzhou, Henan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.